VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944,084 | +2.9% | 35,083 | +15.1% | 0.04% | +8.1% |
| Q2 2023 | $917,452 | -6.7% | 30,470 | +0.2% | 0.04% | -9.8% |
| Q1 2023 | $983,505 | +14.2% | 30,402 | +1.2% | 0.04% | +10.8% |
| Q4 2022 | $861,319 | +10.4% | 30,053 | -7.1% | 0.04% | 0.0% |
| Q3 2022 | $780,000 | -13.3% | 32,358 | -1.6% | 0.04% | -5.1% |
| Q2 2022 | $900,000 | -24.9% | 32,882 | +5.2% | 0.04% | -11.4% |
| Q1 2022 | $1,199,000 | – | 31,265 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |